Company Information
Industry 制造业
Company Introduction 公司创建于1999年,2020年10月30日完成股份制改革。公司占地面积35万平方米,拥有员工1600多名,数十条行业领先的自动化产线,10万级GMP车间3万平方米,生产环境达到国际标准。公司具备突出的规模化、自动化、信息化生产优势,是中国专业的医用敷料制造商与出口商。 公司专注一次性医用敷料、卫生消毒用品、日常护理用品研发、生产及销售。目前产品包括手术耗材类、伤口护理类、清洁消毒类产品、防护类、高分子类、非织造布类六大类产品,覆盖医用敷料、医疗感控和健康生活消费品三大领域。 经过26年的积累,凭借快捷的服务、优良的品质和良好的信誉,公司已经搭建了“国内+国外”,“线上+线下”、“院线+药房”的全方位营销平台。国内销售网络已覆盖全国31个省市自治区,目前超过5万家药房在售健尔康产品。国外,公司产品远销美洲、欧洲、亚洲、中东、非洲,尤其在美国、欧洲市场已垫定了稳定的市场地位。 公司现为“中国医药保健品进出口商会副理事长单位”、“医用敷料出口五强企业”、“江苏省民营科技企业”、“江苏省自营出口先进企业”、“常州医疗器械行业协会副会长单位”。 回顾过去,展望未来,健尔康医疗始终坚持“以服务为基础,以质量求生存,以科技求发展”的经营理念,为全球消费者提供更加安全有效、舒适环保、使用便捷的产品,为全球的医疗事业做出应有的贡献!
Main Business 医用敷料等一次性医疗器械及消毒卫生用品研发、生产和销售。
Legal Representative 陈国平
Top Executives
董事长:陈国平
董事:虞珊,仲琴,刘平,甘厚全,陈罗俊
独立董事:董寅生,张建,胡晓明
Top 5 Shareholder
Shareholder name Nature Holding Date
陈国平限售股43.43%06/11/2024
陈麒宇限售股19.53%06/11/2024
常州和聚实业投资合伙企业(有限合伙)限售股5.25%06/11/2024
郭息孝限售股3.04%06/11/2024
常州顺赢实业投资合伙企业(有限合伙)限售股2.25%06/11/2024
Company Secretary 刘平
Solicitors 上海市广发律师事务所
Auditors 天衡会计师事务所(特殊普通合伙)
Tel No 0519-82446601
Fax No 0519-82446620
Website www.chinajek.com
Email lp@chinajek.com
Company Address
Register: 江苏省常州市金坛区直溪镇工业集中区健尔康路1号
Office: 江苏省常州市金坛区直溪镇工业集中区健尔康路1号
Listing Date 07/11/2024
Shares Capital
Shares Capital: 120,000,000
Total A Share: 120,000,000
Listed A Share: 29,398,886
Non-tradable A Share: 90,601,114
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 1.370
DPS(RMB)* --
NBV Per Share(RMB)* ¥ 10.100
Market Capitalization(RMB) 2.323B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.